MX2021005984A - Bacterias christensenellaceae que incluyen christensenella minuta y usos de las mismas. - Google Patents

Bacterias christensenellaceae que incluyen christensenella minuta y usos de las mismas.

Info

Publication number
MX2021005984A
MX2021005984A MX2021005984A MX2021005984A MX2021005984A MX 2021005984 A MX2021005984 A MX 2021005984A MX 2021005984 A MX2021005984 A MX 2021005984A MX 2021005984 A MX2021005984 A MX 2021005984A MX 2021005984 A MX2021005984 A MX 2021005984A
Authority
MX
Mexico
Prior art keywords
bacteria including
christensenella minuta
christensenellaceae bacteria
christensenellaceae
disorders
Prior art date
Application number
MX2021005984A
Other languages
English (en)
Inventor
Herranz Yolanda Sanz
Del Pulgar Villanueva Eva Maria Gomez
Feliu Ana Agusti
Laguna Maria Carmen Cenit
Original Assignee
Consejo Superior Investigacion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior Investigacion filed Critical Consejo Superior Investigacion
Publication of MX2021005984A publication Critical patent/MX2021005984A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a bacterias Christensenellaceae que incluyen Christensenella minuta cepa DSM 32891, a los componentes celulares, metabolitos y moléculas secretadas de las mismas, y a composiciones que comprenden los productos anteriores, y también al uso de dicha cepa para la prevención y/o el tratamiento de trastornos afectivos o del estado de ánimo, tales como depresión, trastornos por estrés, trastornos de ansiedad y migraña.
MX2021005984A 2018-11-28 2019-11-27 Bacterias christensenellaceae que incluyen christensenella minuta y usos de las mismas. MX2021005984A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201831153A ES2763350B2 (es) 2018-11-28 2018-11-28 Cepa de christensenella minuta y uso de la misma
PCT/EP2019/082793 WO2020109414A1 (en) 2018-11-28 2019-11-27 Christensenellaceae bacteria including christensenella minuta and uses thereof

Publications (1)

Publication Number Publication Date
MX2021005984A true MX2021005984A (es) 2021-09-23

Family

ID=68987654

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021005984A MX2021005984A (es) 2018-11-28 2019-11-27 Bacterias christensenellaceae que incluyen christensenella minuta y usos de las mismas.

Country Status (12)

Country Link
US (1) US20220000942A1 (es)
EP (1) EP3887504A1 (es)
JP (1) JP2022513154A (es)
KR (1) KR20210097716A (es)
CN (1) CN113166714A (es)
AU (1) AU2019389278A1 (es)
BR (1) BR112021010178A8 (es)
CA (1) CA3120905A1 (es)
ES (1) ES2763350B2 (es)
IL (1) IL283418A (es)
MX (1) MX2021005984A (es)
WO (1) WO2020109414A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3114106A1 (fr) * 2020-09-16 2022-03-18 Lnc Therapeutics Souche bactérienne appartenant au genre Christensenella et compositions
CN115998772A (zh) * 2021-04-06 2023-04-25 慕恩（广州）生物科技有限公司 一种细菌菌株及组合物和用途
FR3126991A1 (fr) * 2021-09-16 2023-03-17 Ysopia Biosciences Souche bactérienne dans la prévention et/ou le traitement de pathologies inflammatoires
CN113975301B (zh) * 2021-11-24 2023-06-30 暨南大学 一种用于提高精子活力的益生菌制剂及其用途
CN114259507B (zh) * 2021-12-27 2022-09-16 暨南大学 一种小克里斯滕森氏菌在制备治疗和/或预防高尿酸相关疾病的药物中的应用
CN114573655B (zh) * 2022-02-22 2023-04-11 中国科学院微生物研究所 胆酸衍生物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265279A1 (en) * 2003-05-08 2004-12-30 Timothy Dinan Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity
MX351670B (es) * 2011-04-29 2017-10-24 Univ Auburn Bacteria bacillus para uso en tratar y prevenir infecciones en animales acuaticos.
US10206958B2 (en) * 2014-04-23 2019-02-19 Cornell University Modulation of fat storage in a subject by altering population levels of christensenellaceae in the GI tract
PL2937424T3 (pl) * 2014-04-23 2017-09-29 National Yang-Ming University Bakteria kwasu mlekowego, kompozycja ją zawierająca i ich zastosowanie
AU2017234120A1 (en) * 2016-03-14 2018-09-20 Holobiome, Inc. Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
MX2018014559A (es) * 2016-07-01 2019-03-28 Nestec Sa Composicion nutritiva que comprende un probiotico para prevenir y/o tratar trastornos de ansiedad y afecciones relacionadas en un mamifero.
FR3063646B1 (fr) * 2017-03-10 2021-07-30 International Nutrition Res Company Bacteries specifiques pour leur utilisation comme medicament en particulier pour lutter contre le surpoids, l'obesite, les maladies cardiometaboliques et les maladies inflammatoires de l'intestin

Also Published As

Publication number Publication date
CN113166714A (zh) 2021-07-23
AU2019389278A1 (en) 2021-06-10
BR112021010178A2 (pt) 2021-08-31
KR20210097716A (ko) 2021-08-09
CA3120905A1 (en) 2020-06-04
US20220000942A1 (en) 2022-01-06
ES2763350B2 (es) 2020-10-13
JP2022513154A (ja) 2022-02-07
WO2020109414A1 (en) 2020-06-04
EP3887504A1 (en) 2021-10-06
IL283418A (en) 2021-07-29
ES2763350A1 (es) 2020-05-28
BR112021010178A8 (pt) 2021-11-30

Similar Documents

Publication Publication Date Title
MX2021005984A (es) Bacterias christensenellaceae que incluyen christensenella minuta y usos de las mismas.
PH12020550523A1 (en) Modulators of the integrated stress pathway
EP4219713A3 (en) Products and compositions
MX2021013193A (es) Cicloalquilos sustituidos como moduladores de la vía integrada del estrés.
SA519400950B1 (ar) Masp-3 تركيبات وطرق لتثبيط لعلاج أمراض واضطرابات مختلفة
MX2021016034A (es) Composiciones y métodos de tratamiento de una afección mediada por th2 usando prevotella.
MX2022004102A (es) Composiciones de oligonucleotidos y metodos de uso de las mismas.
MX2018012655A (es) Compuestos y metodos para tratamiento de afecciones neurologicas y cardiovasculares.
MX2022012474A (es) Compuestos y usos de estos.
MX2022003166A (es) Moduladores de il-17a y usos de los mismos.
ZA202207804B (en) Compounds and uses thereof
MX2020006191A (es) Bacteriocinas terapeuticas.
MX2020008265A (es) Derivados farmaceuticos del anillo heterobiciclico 6,5.
PH12020550023A1 (en) Compositions for treating stress-related disorders
MX2022009308A (es) Compuestos y usos de estos.
PH12019502469A1 (en) Novel fragrance compositions and products with mood enhancing effects
MX2020006355A (es) Pirrolidinamidas ii sustituidas.
WO2019045287A3 (ko) 찔레열매 추출물의 분획물을 유효성분으로 포함하는 면역 질환의 예방, 개선 또는 치료용 조성물
MX2022009366A (es) Compuestos y usos de estos.
MX2021003515A (es) Compuestos polimorficos y usos de los mismos.
MX2023004869A (es) Anticuerpos contra sars-cov-2 y usos de los mismos.
GB2571850A (en) Maca compositions and methods of use
MX2021006977A (es) Anellosomas y metodos de uso.
MX2023005436A (es) Compuestos y usos de estos.
MX2020008138A (es) Formulaciones parentales y usos de estas.